<DOC>
	<DOCNO>NCT02990247</DOCNO>
	<brief_summary>Asthma exacerbation account significant morbidity disproportionate health care cost . However , currently available biomarker lung function parameter accurately predict risk future exacerbation . The current work aim evaluate rest ventilatory flow apply new technique call anharmonic morphological analysis respiratory signal ( AMARS ) . We hypothesize monitor AMARS potentially able detect increase risk asthma exacerbation .</brief_summary>
	<brief_title>Home Telemonitoring Resting Spontaneous Breathing Severe Asthma : Pilot Study</brief_title>
	<detailed_description>Asthma exacerbation represent acute sub-acute worsening symptom lung function patient 's usual status . Early detection exacerbation major public health issue . In clinic , management asthma involve asthma control questionnaires pulmonary function test ( Forced Expiratory Volume ( FEV1 ) , Fractional exhale nitric oxide FeNO ) . At home , peak expiratory flow rate ( PEFR ) measure peak flow meter aid monitor asthma ability predict asthma exacerbation remain controversial . Anharmonic morphological analysis respiratory signal ( AMARS ) new morpho-mathematic biomarker produce objective accurate measure shape ventilatory flow . The current study aim monitor rest spontaneous breathe home asthmatic . Changes AMARS may predictor early symptom asthma exacerbation . We recruit 120 asthmatic patient . Patients give portable device telemonitoring . Resting spontaneous breathing measure 2-3 min morning evening , twice week least 12 month . Three visit schedule Clinical Investigation Center ( V1 ) , 6-month ( V2 ) 12-month ( V3 ) telemonitoring period .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>male female age 18 yr write informed consent diagnosis asthma accord Global Initiative For Asthma ( GINA ) criteria history least one moderate severe exacerbation previous 12 month smoker former smoker ( &gt; 10 packsyear ) concomitant asthma exacerbation ( V1 ) prisoner protect adult affiliation French Social Security System</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Exacerbations</keyword>
	<keyword>Telemonitoring</keyword>
	<keyword>Biomarkers</keyword>
</DOC>